Cardiology

60-day mortality not significantly lower with ECMO in ARDS

(HealthDay)—For patients with very severe acute respiratory distress syndrome (ARDS), 60-day mortality is not significantly lower with venovenous extracorporeal membrane oxygenation (ECMO) than with continued conventional ...

Pediatrics

As pediatric use of iNO increased, mortality rates dropped

Use of inhaled nitric oxide (iNO) among pediatric patients has increased since 2005 and, during a 10-year time period, mortality rates dropped modestly as the therapeutic approach was applied to a broader range of health ...

Pediatrics

Inhaled nitric oxide doesn't cut mortality for neonates

(HealthDay)—For neonates born at 22 to 29 weeks' gestation with respiratory distress syndrome (RDS), off-label use of inhaled nitric oxide (iNO) is not associated with reduced mortality, according to a study published online ...

Cardiology

Higher positive end-expiratory pressure no benefit in ARDS

(HealthDay)—For patients with acute respiratory distress syndrome (ARDS), higher positive end-expiratory pressure (PEEP) levels are not likely to improve clinical outcomes, according to a review published in the October ...

Cardiology

Conservative fluid management benefits black ARDS patients

(HealthDay)—For patients with acute respiratory distress syndrome (ARDS), conservative fluid management is associated with reduced mortality for non-Hispanic black, but not white, patients, according to a study published ...

Diseases, Conditions, Syndromes

Lung therapy hope for critical illness

Scientists have pinpointed a chemical signal that worsens inflammation linked to a life-threatening lung condition.

Diseases, Conditions, Syndromes

The high cost of surviving acute respiratory distress syndrome

According to a new multicenter study, nearly half of previously employed adult survivors of acute respiratory distress syndrome were jobless one year after hospital discharge, and are estimated to have lost an average of ...

page 21 from 29